Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 2, 2010International Journal of Cancer

Regulatory T cells in tumor immunity

View Full Paper
Ask AI
Bookmark
Share

Authors

HNHiroyoshi NishikawaNational Cancer Centre JapanShimon SakaguchiShimon SakaguchiScripps Research Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nishikawa et al. (2010) studied this question.

synapsesocial.com/papers/6a0982be00217ed3fb33f8adhttps://doi.org/10.1002/ijc.25429
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity2001 · 67 citations
  2. 2Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells2012 · 463 citations
  3. 3Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells2005 · 130 citations
  4. 4CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion2008 · 259 citations
  5. 5Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors2005 · 433 citations